Attached files

file filename
8-K - FORM 8-K - KEWAUNEE SCIENTIFIC CORP /DE/v233127_8k.htm

Kewaunee Scientific Reports Sales and Earnings For First Quarter

STATESVILLE, N.C., Aug. 24, 2011 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported sales and earnings for its first quarter ended July 31, 2011.

Sales for the quarter were $26,321,000, up 5.9% from sales of $24,858,000 in the first quarter last year. Net earnings for the quarter were $22,000, or $0.01 per diluted share, down from net earnings of $657,000, or $0.25 per diluted share, in the first quarter of the prior year. Earnings for the quarter were unfavorably impacted by lower selling prices and higher costs paid for raw materials, particularly steel and epoxy resin. Additionally, costs associated with the startup of manufacturing for the Company's new laminate furniture product line reduced after-tax earnings by approximately $188,000, or $0.07 per diluted share.

Domestic sales for the quarter were $23,396,000, up from sales of $20,948,000 in the first quarter last year. The domestic marketplace for laboratory projects was generally unchanged from recent quarters, as demand for larger projects continued to hold up relatively well, while demand for small and mid-sized laboratory projects remained well below pre-recession levels. International sales for the quarter were $2,925,000, down from $3,910,000 in the first quarter last year. Although not reflected in the sales figure, the recovery in the international laboratory marketplace appears to be well underway, as the Company is seeing and bidding increasing numbers of opportunities in Asia and the Middle East. The Company's expanded and strengthened international sales representation is helping the Company take early advantage of the recovery.

The order backlog grew to a record $69.7 million at July 31, 2011, up from $65.7 million at April 30, 2011 and $66.9 million at July 31, 2010.

"Dramatic increases in raw material prices, particularly steel and epoxy resin, which is petroleum-based, severely pressured profit margins during the quarter," said Mr. Shumaker, President and Chief Executive Officer. "Facing these higher costs, we accelerated and expanded our cost reduction efforts throughout the Company. We now have identified and put in place new initiatives that are projected to reduce our annual costs by over $3 million. Savings related to many of these initiatives will begin in the second quarter and are expected to continue throughout the remainder of the fiscal year.

"Looking forward for the remainder of this fiscal year, we expect earnings for the second quarter to be much improved over the first quarter, although below last year's strong second quarter results," Mr. Shumaker continued. "We also expect the second half of the fiscal year to be much better than the first. Our projections are based on an analysis of orders in the order backlog, cost savings initiatives underway, increased sales opportunities in the international marketplace, and sales and earnings benefits from new products."

The Company continues to have a strong balance sheet. Working capital was $22.1 million at July 31, 2011, as compared to $18.9 million at the end of the first quarter last year. Cash on hand was $3.6 million at the end of the quarter, as compared to $2.3 million at the end of the first quarter last year. Short-term borrowings under the Company's $14 million bank line of credit were $8.7 million at the end of the quarter, as compared to $7.5 million at the end of the first quarter last year, and total bank borrowings and capital lease obligations were $12.6 million, as compared to $7.7 million at the end of the first quarter last year. The debt-to-equity ratio was .40-to-1 at the end of the quarter, as compared to .25-to-1 at the end of the first quarter last year.

Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of laboratory, technical and laminate furniture products. Laboratory furniture products include both steel and wood cabinetry, fume hoods, adaptable modular systems, moveable workstations, biological safety cabinets and epoxy resin counters and sinks. Technical furniture products include column systems, slotted-post systems, pedestal systems and stand-alone benches. Laminate furniture includes laminate casework, systems and related products for educational, healthcare and industrial applications.

The Company's corporate headquarters are located in Statesville, North Carolina. Three manufacturing facilities are located in Statesville, NC serving the domestic and international markets. One manufacturing facility is located in Bangalore, India serving the local and Asian markets. The Company has subsidiaries in Singapore and India. Kewaunee Scientific's website is located at http://www.kewaunee.com.

Certain statements in this release constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, services, and prices.

Contact:

D. Michael Parker


704/871-3290



Consolidated Statements of Operations [unaudited]

(in thousands, except per share data)








Three Months Ended


July 31

2011

July 31

2010







    Net sales

$26,321

$24,858

    Cost of products sold

22,133

19,859




    Gross profit

4,188

4,999

    Operating expenses

3,955

3,901




    Operating earnings

233

1,098

    Other expense

(1)

--




    Interest expense

(95)

(45)




    Earnings before income taxes

137

1,053

    Income tax expense

29

329




    Net earnings

108

724

    Less: net earnings attributable to



       the noncontrolling interest

(86)

(67)




    Net earnings attributable to



        Kewaunee Scientific Corporation

$22

$657




    Net earnings per share attributable to



        Kewaunee Scientific Corporation stockholders



          Basic

$0.01

$0.26

          Diluted

$0.01

$0.25




    Weighted average number of common



      shares outstanding



          Basic

2,579

2,573

          Diluted

2,580

2,578







Condensed Consolidated Balance Sheets

(in thousands)





July 31

2011

April 30

2011

Assets

[unaudited]





Cash and cash equivalents

$2,652

$2,402

Restricted cash

908

553

Receivables, less allowances

27,282

27,346

Inventories

10,261

10,466

Prepaid expenses and other current assets

2,345

1,612

  Total Current Assets

43,448

42,379

Net property, plant and equipment

16,202

16,575

Other assets

4,112

4,104

Total Assets

$63,762

$63,058




Liabilities and Stockholders' Equity



Short-term borrowings

$8,672

$6,588

Current obligations under capital leases and long-term debt

284

283

Accounts payable

7,890

9,770

Other current liabilities

4,531

3,623

  Total Current Liabilities

21,377

20,264

Other non-current liabilities

9,440

9,778

  Total Liabilities

30,817

30,042

Noncontrolling interest

1,634

1,525

Kewaunee Scientific Corporation equity

31,311

31,491

  Total Equity

32,945

33,016

Total Liabilities and Equity

$63,762

$63,058